(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 20.39% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.98%.
Evolent Health's revenue in 2026 is $1,888,826,000.On average, 17 Wall Street analysts forecast EVH's revenue for 2026 to be $282,552,440,304, with the lowest EVH revenue forecast at $265,905,242,388, and the highest EVH revenue forecast at $304,261,286,235. On average, 15 Wall Street analysts forecast EVH's revenue for 2027 to be $327,319,904,970, with the lowest EVH revenue forecast at $292,900,698,468, and the highest EVH revenue forecast at $378,611,271,522.
In 2028, EVH is forecast to generate $370,175,191,497 in revenue, with the lowest revenue forecast at $320,458,559,883 and the highest revenue forecast at $425,178,433,260.